EC Number   |
Title |
Organism |
|---|
   3.4.21.98 | A 3D structural model and dynamics of hepatitis C virus NS3/4A protease (genotype 4a, strain ED43) suggest conformational instability of the catalytic triad: implications in catalysis and drug resistivity |
Hepacivirus hominis |
| 3.4.21.98 | A 3D structural model and dynamics of hepatitis C virus NS3/4A protease (genotype 4a, strain ED43) suggest conformational instability of the catalytic triad: implications in catalysis and drug resistivity |
Hepacivirus hominis ED43 |
| 3.4.21.98 | A complete mutational fitness map of the hepatitis C virus nonstructural 3 protease: Relation to recognition by cytotoxic T lymphocytes |
Hepacivirus hominis |
| 3.4.21.98 | A hepatitis C virus (HCV) NS3/4A protease-dependent strategy for the identification and purification of HCV-infected cells |
Hepacivirus hominis |
| 3.4.21.98 | A quantum mechanics/molecular mechanics study of the reaction mechanism of the hepatitis C virus NS3 protease with the NS5A/5B substrate |
Hepacivirus hominis |
| 3.4.21.98 | A screening method for identifying disruptions in interferon signaling reveals HCV NS3/4a disrupts Stat-1 phosphorylation |
Hepacivirus hominis |
| 3.4.21.98 | A systematic approach to the optimization of substrate-based inhibitors of the hepatitis C virus NS3 protease: discovery of potent and specific tripeptide inhibitors |
Hepacivirus hominis |
| 3.4.21.98 | A wide range of NS3/4A protease catalytic efficiencies in HCV-infected individuals |
Hepacivirus hominis |
| 3.4.21.98 | Activity of compounds from Chinese herbal medicine Rhodiola kirilowii (Regel) Maxim against HCV NS3 serine protease |
Hepacivirus hominis |
| 3.4.21.98 | Activity of purified hepatitis C virus protease NS3 on peptide substrates |
Hepacivirus hominis |
